Login / Signup

Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial.

Tetsuro YoshidaAkihiro NakamuraJunichi FunadaMari AminoWataru ShimizuMasayuki FukuzawaSaori WatanabeTakuya HayashiTakeshi YamashitaKen OkumuraMasaharu Akao
Published in: Circulation (2022)
Keyphrases
  • phase iii
  • study protocol
  • atrial fibrillation
  • middle aged
  • venous thromboembolism
  • phase ii
  • clinical trial
  • community dwelling
  • randomized controlled trial
  • open label